Amedisys, Inc. Financials

Market Capitalization $3.15 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	35.46
Forward PE	18.81
Price to Sales TTM	$1.33
Price to Book MRQ	$2.63
Enterprise to Revenue	1.45
Enterprise to EBITDA	14.10

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	3.79%
Operating Margin	10.11%
Return on Assets TTM	6.36%
Return on Equity TTM	7.15%

Income Statement

Revenue TTM	$2,371,691,008
Revenue per Share TTM	$72.42
Quarterly Revenue Growth	4.10%
Gross Profit TTM	$1,028,531,008
EBITDA	$351,581,000
Net Income to Common TTM	$89,843,000
Diluted EPS TTM	$2.71
Quarterly Earnings Growth YoY	323.70%

Balance Sheet

Total Cash MRQ	$284,880,992
Total Cash per Share MRQ	$8.68
Total Debt MRQ	$
Total Debt to Equity MRQ	36.30
Current Ratio MRQ	1.29
Book Value per Share MRQ	$36.55

Cash Flow

Operating Cash Flow TTM	$224,519,008
Levered Free Cash Flow TTM	$279,988,736

AMED Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	32,776,148
Float Shares	32,175,060
Avg 10 Volume	547,040
Avg 30 Volume	None
Shares Short	1,965,438
Short Ratio	6.29
Short % of Shares	6.09%
% Held by Insiders	1.96%
% Held by Institutions	93.03%

Stock Price Summary

Beta	0.94
Fifty Two Week Low	$82.15
Fifty Two Week High	$98.95
Fifty Two Week Change	-1.20%
Day 50 MA	$95.50
Day 200 MA	$93.15

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2014-06-11
Last Split Factor
Last Split Date	2006-12-05